Taken together, these findings highlight the potential therapeutic value of adding GLP-1RA to SGLT2i as a novel treatment strategy for patients with MASLD
The main takeaway: Tirzepatides digestive effects are connected to how the medication works, but severe, persistent, or worsening symptoms still deserve medical attention
Study Limitations and Future Research Directions The interpretation of the findings is limited by the small GLP-1RA cohort (n = 12), baseline imbalances in BMI and sex, the single-center retrospective design, incomplete autoantibody testing, and a median follow-up of approximately eight months
Alternatively, hepatic steatosis can be alleviated by regulating insulin clearance in the liver [39]
skin tone appears uneven, and patches of skin are darker than the surrounding areas
Participants would administer 0.19, 0.37 or 0.74 ml to correspond to 0.25, 0.5 and 1 mg, respectively